Norgine

Exited

Specialty pharmaceutical company

Norgine is tracked in the Tech.eu funding database. Based in Amsterdam, Netherlands; active in Healthtech. Acquired by Goldman Sachs in 2022. Data as of 21 Aug 2026.

Amsterdam, Netherlandsnorgine.com ↗

Healthtech

← All companies

Total raised

€0

Funding rounds

Investors

distinct backers

Active since

—

Funding rounds

0 rounds

No funding rounds recorded.

Exit

Type

acquisition

Date

Jun 2022

Value

€1.8B

Acquiror

Goldman Sachs (United States of America)

Similar companies

same sector or country

Philips

Norgine

Funding rounds

Exit

Related news

Similar companies